Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Understanding Reasonable Fear vs. Credible Fear Interviews: A Critical Guide for Immigrants Facing Removal

Client Alert

Washington, D.C. – In a timely new article, Rob Ratliff, Immigration Attorney and former Immigration Judge, clarifies the differences between Reasonable Fear Interviews and Credible Fear Interviews, essential processes for noncitizens fearing persecution or torture. Published at www.removal-defense.com, the article explains concepts central to recent judicial rulings, including U.S. District Judge Brian Murphy’s order addressing the Trump administration’s unlawful deportations to South Sudan, which violated his April 18, 2025, injunction (U.S. District Court, Massachusetts).

Reasonable Fear Interviews apply to individuals with prior removal orders, like those with aggravated felonies or reentry after deportation (INA § 238(b), § 241(a)(5)), assessing a “reasonable possibility” of persecution or torture. Successful cases lead to withholding-only proceedings for withholding of removal or Convention Against Torture (CAT) protection (8 CFR § 208.31). Credible Fear Interviews target those in expedited removal, like border apprehensions, requiring a lower “significant possibility” of eligibility for asylum, withholding, or CAT protection, potentially leading to an Asylum Merits Interview or removal proceedings (INA § 235(b)(1); 8 CFR § 208.30).

Both allow an immigration judge (IJ) review of negative findings, but the IJ review is final with no appeal (8 CFR § 1208.31(g); 8 CFR § 1003.42), unless a new hearing is granted. An alien may consult with counsel prior to a hearing with an IJ or asylum officer, but during asylum officer interviews, attorneys are limited to observation and consultation (8 CFR § 208.30(d)(4); 8 CFR § 208.31(c)). It is the discretion of the IJ or asylum officer, is the attorney is permitted provide brief argument on behalf of their client. Notice for a hearing is provided via Form I-863 or Notices to Appear (8 CFR § 1208.31(e); 8 CFR § 1239.1).

“Judge Murphy’s ruling underscores the due process issues in these screenings,” said Ratliff. “Our article connects these processes to real-world cases.” Read the full analysis at www.removal-defense.com.


Corporate Transparency Act: Business Owners Must Act Now

The Corporate Transparency Act requires all reporting companies to file their Beneficial Ownership Information (BOI) report by year-end to avoid penalties. Companies formed before January 1, 2024, have less than six months to comply. Learn more in a client alert by BMD Member Blake Gerney.

New Medicare Billing Rules: What MFTs, MHCs, and IOP Providers Need to Know

Starting January 1, 2024, Medicare began covering services provided to Medicare beneficiaries by marriage and family therapists, mental health counselors, and Intensive Outpatient Program (IOP) services. With this change, Medicare has become the primary payer for these services.

Chevron Doctrine No More: What the Supreme Court’s Ruling Means for Agency Authority

On June 28, 2024, the Supreme Court invalidated the Chevron doctrine, nearly 40 years after it first took effect.

Ohio Board of Pharmacy Update: Key Regulatory Changes and Proposals You Need to Know

The Ohio Board of Pharmacy (BOP) has rescinded certain OAC rules (OAC 4729:5-18-01 through 4729:5-18-06), removing regulations on office-based opioid treatment (OBOT) clinics. The rescissions took effect on June 3, 2024. The BOP also published a new rule, OAC 4729:8-5-01, which sets explicit reporting guidelines for licensed dispensaries and became effective on June 7, 2024.

LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”